Thermo Fisher Scientific Inc Total Liabilities
Thermo Fisher Scientific Inc total liabilities. Based on the latest financial reports, Thermo Fisher Scientific Inc (TMO) has total liabilities worth $52.00 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Thermo Fisher Scientific Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Thermo Fisher Scientific Inc (1985–2024)
Total liabilities of Thermo Fisher Scientific Inc from 1985 to 2024. This chart illustrates how Thermo Fisher Scientific Inc's total liabilities have evolved over time, based on quarterly financial data. Explore TMO strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Thermo Fisher Scientific Inc Competitors by Total Liabilities
The table below lists competitors of Thermo Fisher Scientific Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bank of China Limited
SHG:601988
|
China | CN¥36.95 Trillion |
|
Shell PLC ADR
NYSE:SHEL
|
USA | $198.73 Billion |
|
CHINA CON.BANK ADR/20 YC1
F:C6TB
|
Germany | €43.36 Trillion |
|
LVMH Moët Hennessy - Louis Vuitton Société Européenne
PA:MC
|
France | €74.70 Billion |
|
Nestlé S.A
F:NESM
|
Germany | €101.08 Billion |
|
International Business Machines
NYSE:IBM
|
USA | $117.56 Billion |
|
BHP Group
MX:BHPN
|
Mexico | MX$60.55 Billion |
|
Siemens Aktiengesellschaft
XETRA:SIE
|
Germany | €92.39 Billion |
Liability Composition Analysis (1985–2024)
This chart breaks down Thermo Fisher Scientific Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see TMO asset base.
Liquidity & Leverage Metrics
Thermo Fisher Scientific Inc Total Liabilities Ratios Explained
Thermo Fisher Scientific Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Thermo Fisher Scientific Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Thermo Fisher Scientific Inc (1985–2024)
The table below shows the annual total liabilities of Thermo Fisher Scientific Inc from 1985 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $47.65 Billion | -8.16% |
| 2023-12-31 | $51.88 Billion | -2.12% |
| 2022-12-31 | $53.01 Billion | -2.11% |
| 2021-12-31 | $54.15 Billion | +56.79% |
| 2020-12-31 | $34.53 Billion | +20.31% |
| 2019-12-31 | $28.71 Billion | +0.21% |
| 2018-12-31 | $28.65 Billion | -8.35% |
| 2017-12-31 | $31.26 Billion | +28.27% |
| 2016-12-31 | $24.37 Billion | +25.07% |
| 2015-12-31 | $19.48 Billion | -12.64% |
| 2014-12-31 | $22.30 Billion | +48.62% |
| 2013-12-31 | $15.01 Billion | +25.27% |
| 2012-12-31 | $11.98 Billion | +1.56% |
| 2011-12-31 | $11.80 Billion | +95.75% |
| 2010-12-31 | $6.03 Billion | -2.34% |
| 2009-12-31 | $6.17 Billion | +0.11% |
| 2008-12-31 | $6.16 Billion | -8.27% |
| 2007-12-31 | $6.72 Billion | -8.59% |
| 2006-12-31 | $7.35 Billion | +404.05% |
| 2005-12-31 | $1.46 Billion | +60.04% |
| 2004-12-31 | $911.17 Million | -9.44% |
| 2003-12-31 | $1.01 Billion | -37.65% |
| 2002-12-31 | $1.61 Billion | -15.51% |
| 2001-12-31 | $1.91 Billion | -17.11% |
| 2000-12-31 | $2.30 Billion | -17.57% |
| 1999-12-31 | $2.80 Billion | -16.30% |
| 1998-12-31 | $3.34 Billion | +11.88% |
| 1997-12-31 | $2.99 Billion | +13.67% |
| 1996-12-31 | $2.63 Billion | +34.27% |
| 1995-12-31 | $1.96 Billion | +14.92% |
| 1994-12-31 | $1.70 Billion | +28.64% |
| 1993-12-31 | $1.32 Billion | +20.76% |
| 1992-12-31 | $1.10 Billion | +85.54% |
| 1991-12-31 | $590.50 Million | +18.48% |
| 1990-12-31 | $498.40 Million | +37.91% |
| 1989-12-31 | $361.40 Million | +17.11% |
| 1988-12-31 | $308.60 Million | +16.76% |
| 1987-12-31 | $264.30 Million | +62.05% |
| 1986-12-31 | $163.10 Million | +35.80% |
| 1985-12-31 | $120.10 Million | -- |
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines,… Read more